Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SHeaph
    Member
    • Nov 2012
    • 13

    #1

    cummeRbund analysis - genes & CDS

    Hi All,

    I produced the following table from a large data set using cufflinks-cuffmerge-cuffdiff. I produced a heatmap with cummeRbund based on the most significant differentially expressed genes at alpha =0.001. I also produced an expressionBarplot for CDS (alpha =0.001). There were more genes in the barplot than identified in the heatmap.

    Can someone please advise what the differences is between both groups?

    genes 65536
    isoforms 93744
    TSS 74511
    CDS 29258
    promoters 65536
    splicing 74511
    relCDS 18751


    Many thanks in advance!
  • sdas125
    Junior Member
    • Dec 2012
    • 1

    #2
    genes & CDS

    CDS signify coding sequences.
    Entire mRNA transcript do not translate into protein. mRNA transcript contains both 5'UTR and 3" UTR, which has versatile functions. Only a part of transcript translate into protein.
    CDS is the part of gene sequence (mRNA sequence) that translate to protein. Generally CDS is a small fraction of entire gene sequence (mRNA sequence).

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...